Ccp Igg Antibody Results 0.5
Plant Centriole and Centrosome Antibody IgG (CC-IgG) ELISA Kit |
|||
| MBS9376362-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Igg Antibody Laboratories manufactures the ccp igg antibody results 0.5 reagents distributed by Genprice. The Ccp Igg Antibody Results 0.5 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Ccp products are available in stock. Specificity: Ccp Category: Igg Group: Antibody Results
True Blue Chloride |
||
| Toronto Research Chemicals | 100mg | EUR 11200 |
|
Description: 71431-30-6 |
||
True north Cryobox1.5/2mLNatural |
||
| Scientific Laboratory Supplies | PK10 | EUR 129.6 |
True Blue Diaceturate Salt |
||
| Toronto Research Chemicals | 100mg | EUR 15000 |
|
Description: 108321-12-6 |
||
Plant Centriole and Centrosome Antibody IgG (CC-IgG) ELISA Kit |
||
| MyBiosource | INQUIRE | Ask for price |
True Blue (TB) Diaceturate Salt |
||
| Polysciences Europe GmbH | 1mg | Ask for price |
|
Description: 108321-12-6 |
||
True Blue (TB) Diaceturate Salt |
||
| Polysciences Europe GmbH | 5mg | Ask for price |
|
Description: 108321-12-6 |
||
Porcine True insulin ELISA kit |
||
| BlueGene | 96T | EUR 700 |
|
Description: ELISA |
||
TruStrip RDT Zaire Ebola Virus antigen (GP) rapid test (visual results in 2-10 mins), 10 cassettes/pk |
|||
| AE-320805-RDT-10 | Alpha Diagnostics | 1 pk | EUR 343.2 |
TruStrip RDT Sulfonamides residues (SAs) rapid test strips, results is 2-10 mins, 50 strips/pk |
|||
| DE-100090-RDT | Alpha Diagnostics | 1 pk | EUR 781.2 |
TruStrip RDT Canine distemper virus (hardpad disease) antigen rapid test card, results is 2-10 mins, 50 cards/pk |
|||
| RV-501200-RDT | Alpha Diagnostics | 1 pk | Ask for price |
TruStrip RDT Beta-Lactam and Tetracyclines rapid test strips, results is 2-10 mins, 50 strips/pk |
|||
| DE-100260-RDT | Alpha Diagnostics | 1 pk | Ask for price |
Multiple organs tumor tissue array, including pathology grade, TNM, clinical stage IHC markers (ER, PR, Her-2) results, 118 cases/208 cores |
|||
| BR20838 | BioCoreUSA | row: 13; column: 16; cores: 208; cases: 118 | EUR 474 |
|
Description: Multiple organs tumor tissue microarray, containing 80 cases of breast invasive carcinoma of no special type, 10 cancer adjacent breast tissue, duplicate cores per case, 4 ovary serous adenocarcinoma, 4 uterus endometrioid adenocarcinoma, 6 rectum adenocarcinoma, 6 colon adenocarcinoma, 2 esophagus squamous cell carcinoma, 2 stomach carcinoma, 2 pancreas adenocarcinoma, 2 lung carcinoma, single core per case |
|||
Breast tumor tissue array (18 of 25), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results,104 cases/208 cores |
|||
| BR20824 | BioCoreUSA | row: 13; column: 16; cores: 208; cases: 104 | EUR 474 |
|
Description: Breast tumor tissue microarray (slide 18 of 2600 cases of breast cancer survey slide set), containing 83 cases of invasive carcinoma of no special type, 4 mucinous carcinoma, 9 medullary carcinoma, 6 invasive lobular carcinoma, 1 each of apocrine carcinoma and cystosarcoma phyllodes, duplicate cores per case |
|||
Breast cancer tissue array with normal breast tissue, including pathology grade, TNM, clinical stage and Her-2 results, 5 cases/5 cores |
|||
| BRC051 | BioCoreUSA | row: 1; column: 5; cores: 5; cases: 5 | EUR 42 |
|
Description: Breast invasive carcinoma of no special type microarray, containing 4 casee of breast invasive carcinoma of no special type and 1 normal breast tissue, single core per case |
|||
Breast invasive carcinoma of no special type tissue array, including pathology grade, TNM, clinical stage and IHC markers (PR, Ki-67, Her-2) results, 10 cases/10 cores |
|||
| FMG010 | BioCoreUSA | row: 3; column: 4; cores: 10; cases: 10 | EUR 78 |
|
Description: Breast invasive carcinoma of no special type tissue microarray, containing 10 cases of breast invasive carcinoma of no special type, single cores per case |
|||
Breast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2) results, 60 cases/120 cores, replacing BR1201a |
|||
| BR1201b | BioCoreUSA | row: 10; column: 12; cores: 120; cases: 60 | EUR 354 |
|
Description: Breast carcinoma tissue microarray (most of triple negative), containing 56 cases invasive carcinoma of no special type, 2 cases invasive papillary adenocarcinoma, 1 each of medullary carcinoma and apocrine carcinoma, duplicate core per case |
|||
Breast cancer tissue array (most of Her-2 subtype), including molecular typing, pathology grade, TNM and clinical stage, with IHC results of ER, PR and Her-2, 50 cases/150 cores |
|||
| BR1510 | BioCoreUSA | row: 10; column: 15; cores: 150; cases: 50 | EUR 354 |
|
Description: Breast carcinoma tissue microarray, containing 45 cases of invasive carcinoma of no special type, 2 medullary carcinoma, 1 each of metaplastic carcinoma, mixed carcinoma and apocrine carcinoma, triplicate cores per case |
|||
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her2, Ki-67) results, 72 cases/72 cores, replacing BC08013d |
|||
| FMG08013e | BioCoreUSA | row: 8; column: 9; cores: 72; cases: 72 | EUR 168 |
|
Description: Breast carcinoma with adjacent normal breast tissue microarray, containing 63 cases of invasive carcinoma of no special type, 6 medullary carcinoma, 3 adjacent normal breast tissue, single core per case |
|||
Her-2 IHC Bio-marker control TMA, with breast invasive carcinoma of no special type, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki-67) results, 10 cases/10 cores, replacing Her2b |
|||
| HER2c | BioCoreUSA | row: 3; column: 4; cores: 10; cases: 10 | EUR 78 |
|
Description: Her-2 IHC Biomarker control tissue microarray of breast invasive carcinoma of no special type, containing 10 cases of invasive invasive carcinoma of no special type, single core per case |
|||
human anti-human CCP IgG(111) |
|||
| E4A11C09-111 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human CCP IgG(54) |
|||
| E4A11C09-54 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human CCP IgG(F3M) |
|||
| E4A11C09-F3M | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human CCP IgG(K3N) |
|||
| E4A11C09-K3N | EnoGene | 100ug | EUR 995 |
human anti-human CCP IgG(S5N) |
|||
| E4A11C09-S5N | EnoGene | 100ug | EUR 995 |